# CLCN1

## Overview
The CLCN1 gene encodes the chloride voltage-gated channel 1 (ClC-1), a transmembrane protein that plays a pivotal role in skeletal muscle function. As a member of the CLC family of chloride channels, ClC-1 is primarily responsible for maintaining the resting membrane potential by facilitating the flow of chloride ions across the muscle cell membrane. This channel is characterized by its dimeric structure, with each monomer forming an independent ion transport pathway, and is regulated by both individual and common gating mechanisms (Stölting2014CLC; Jentsch2018CLC). The proper function of ClC-1 is essential for muscle excitability and relaxation, preventing excessive depolarization during muscle activity and ensuring normal muscle contraction. Mutations in the CLCN1 gene can lead to myotonia congenita, a condition marked by muscle stiffness and delayed relaxation, highlighting the clinical significance of this gene and its encoded protein (Zhang2000Functional; Poroca2017ClC).

## Structure
The CLCN1 gene encodes the chloride voltage-gated channel 1 protein, which is primarily expressed in skeletal muscle. This protein is part of the CLC family and typically forms a homodimer, with each subunit containing 18 transmembrane helices (Jentsch2018CLC). The protein's structure includes two cystathionine-β-synthase (CBS) domains, which are involved in the regulation of chloride conductance and slow gating mechanisms (Wang2019Structure). 

The transmembrane domain (TMD) of CLC-1 exhibits a bifurcated pore structure, characteristic of the dimeric architecture of CLC proteins, with each monomer forming an independent ion transport pathway (Park2018Structure). The chloride-selectivity filter is formed by helices aN, aF, and aD, creating an electrostatically positive environment for chloride ion binding (Park2018Structure). The Glu gate, a central glutamate residue, acts as a fast gate conferring voltage dependence and is crucial for the channel's function (Wang2019Structure).

The CLC-1 channel's quaternary structure is characterized by a strong dimerization interface, with each subunit forming a separate protopore (Jentsch2018CLC). The protein's structure is further distinguished by a unique outward shift of the Tyr C side chain, contributing to pore widening and reduced kinetic barriers for ion passage (Park2018Structure). The protein may undergo post-translational modifications, such as phosphorylation, which can affect channel activity. Splice variants of CLCN1 can lead to different isoforms with distinct functional properties.

## Function
The CLCN1 gene encodes the ClC-1 protein, a chloride channel primarily expressed in skeletal muscle cells. This protein plays a crucial role in maintaining the resting membrane potential by facilitating the flow of chloride ions across the cell membrane. In healthy muscle cells, ClC-1 provides a large resting chloride conductance, which is essential for stabilizing the membrane potential and preventing excessive depolarization during muscle activity (Jentsch2005PHYSIOLOGICAL; StÃ¶lting2014CLC).

ClC-1 channels function as dimers, with each monomer having its own pore, and are gated by both individual and common gates. This structural feature allows ClC-1 to conduct chloride ions efficiently, minimizing changes in voltage and maintaining muscle excitability (Poroca2017ClC; Jentsch2005PHYSIOLOGICAL). The channel's specific anion conduction and gating properties enable it to provide a large resting chloride conductance with minimal interference with action potentials, reducing sodium influx and subsequent ATP consumption (StÃ¶lting2014CLC).

The proper function of ClC-1 is vital for muscle excitability and relaxation, ensuring normal muscle contraction and preventing conditions like myotonia congenita, which is characterized by muscle stiffness due to impaired chloride conductance (Poroca2017ClC; StÃ¶lting2014CLC).

## Clinical Significance
Mutations in the CLCN1 gene, which encodes the chloride channel protein ClC-1, are associated with myotonia congenita, a genetic muscle disorder characterized by muscle stiffness and delayed relaxation after contraction. This condition manifests in two forms: Thomsen's disease, which is autosomal dominant, and Becker's myotonia, which is autosomal recessive (Zhang2000Functional; Wu2002Novel; Brugnoni1999Identification). 

Mutations in CLCN1 lead to a loss of function of the chloride channel, resulting in muscle membrane hyperexcitability and repetitive firing of action potentials (Zhang2000Functional; Brugnoni1999Identification). These mutations include missense, nonsense, splice-site, frameshift, and deletions, contributing to the genetic heterogeneity of the disorder (Tang2011Physiology; Sun2001Spectrum). Some mutations, such as I329T and R338Q, significantly alter the voltage dependence of channel opening, impairing muscle excitability (Zhang2000Functional).

The clinical presentation of myotonia congenita can vary, with some mutations exhibiting incomplete dominance or reduced penetrance, complicating the inheritance patterns (PlassartSchiess1998Novel). The genetic diversity and varying clinical severities underscore the complexity of CLCN1-related myotonia congenita (Sun2001Spectrum; Ulzi2012Myotonia).


## References


[1. (Park2018Structure) Eunyong Park and Roderick MacKinnon. Structure of the clc-1 chloride channel from homo sapiens. eLife, May 2018. URL: http://dx.doi.org/10.7554/elife.36629, doi:10.7554/elife.36629. This article has 86 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.36629)

[2. (Tang2011Physiology) Chih-Yung Tang and Tsung-Yu Chen. Physiology and pathophysiology of clc‐1: mechanisms of a chloride channel disease, myotonia. BioMed Research International, January 2011. URL: http://dx.doi.org/10.1155/2011/685328, doi:10.1155/2011/685328. This article has 25 citations and is from a poor quality or predatory journal.](https://doi.org/10.1155/2011/685328)

[3. (Jentsch2018CLC) Thomas J. Jentsch and Michael Pusch. Clc chloride channels and transporters: structure, function, physiology, and disease. Physiological Reviews, 98(3):1493–1590, July 2018. URL: http://dx.doi.org/10.1152/physrev.00047.2017, doi:10.1152/physrev.00047.2017. This article has 308 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1152/physrev.00047.2017)

[4. (Brugnoni1999Identification) Raffaella Brugnoni, Stefania Galantini, Paolo Confalonieri, Maria Rosa Balestrini, Ferdinando Cornelio, and Renato Mantegazza. Identification of three novel mutations in the major human skeletal muscle chloride channel gene (clcn1), causing myotonia congenita. Human Mutation, 14(5):447–447, November 1999. URL: http://dx.doi.org/10.1002/(SICI)1098-1004(199911)14:5<447::AID-HUMU13>3.0.CO;2-Z, doi:10.1002/(sici)1098-1004(199911)14:5<447::aid-humu13>3.0.co;2-z. This article has 30 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/(SICI)1098-1004(199911)14:5)

[5. (PlassartSchiess1998Novel) E. Plassart-Schiess, A. Gervais, B. Eymard, A. Lagueny, J. Pouget, J. M. Warter, M. Fardeau, T. J. Jentsch, and B. Fontaine. Novel muscle chloride channel ( clcn1 ) mutations in myotonia congenita with various modes of inheritance including incomplete dominance and penetrance. Neurology, 50(4):1176–1179, April 1998. URL: http://dx.doi.org/10.1212/wnl.50.4.1176, doi:10.1212/wnl.50.4.1176. This article has 63 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/wnl.50.4.1176)

[6. (Poroca2017ClC) Diogo R. Poroca, Ryan M. Pelis, and Valérie M. Chappe. Clc channels and transporters: structure, physiological functions, and implications in human chloride channelopathies. Frontiers in Pharmacology, March 2017. URL: http://dx.doi.org/10.3389/fphar.2017.00151, doi:10.3389/fphar.2017.00151. This article has 87 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2017.00151)

[7. (Jentsch2005PHYSIOLOGICAL) Thomas J. Jentsch, Mallorie Poët, Jens C. Fuhrmann, and Anselm A. Zdebik. Physiological functions of clc cl−channels gleaned from human genetic disease and mouse models. Annual Review of Physiology, 67(1):779–807, March 2005. URL: http://dx.doi.org/10.1146/annurev.physiol.67.032003.153245, doi:10.1146/annurev.physiol.67.032003.153245. This article has 191 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1146/annurev.physiol.67.032003.153245)

[8. (StÃ¶lting2014CLC) Gabriel StÃ¶lting, Martin Fischer, and Christoph Fahlke. Clc channel function and dysfunction in health and disease. Frontiers in Physiology, October 2014. URL: http://dx.doi.org/10.3389/fphys.2014.00378, doi:10.3389/fphys.2014.00378. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphys.2014.00378)

[9. (Sun2001Spectrum) Chen Sun, Lisbeth Tranebjærg, Torberg Torbergsen, Gösta Holmgren, and Marijke Van Ghelue. Spectrum of clcn1 mutations in patients with myotonia congenita in northern scandinavia. European Journal of Human Genetics, 9(12):903–909, December 2001. URL: http://dx.doi.org/10.1038/sj.ejhg.5200736, doi:10.1038/sj.ejhg.5200736. This article has 88 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.ejhg.5200736)

[10. (Ulzi2012Myotonia) Gianna Ulzi, Marzia Lecchi, Valeria Sansone, Elisa Redaelli, Eleonora Corti, Domenica Saccomanno, Serena Pagliarani, Stefania Corti, Francesca Magri, Monika Raimondi, Grazia D’Angelo, Anna Modoni, Nereo Bresolin, Giovanni Meola, Enzo Wanke, Giacomo P. Comi, and Sabrina Lucchiari. Myotonia congenita: novel mutations in clcn1 gene and functional characterizations in italian patients. Journal of the Neurological Sciences, 318(1–2):65–71, July 2012. URL: http://dx.doi.org/10.1016/j.jns.2012.03.024, doi:10.1016/j.jns.2012.03.024. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jns.2012.03.024)

[11. (Zhang2000Functional) Jie Zhang, Saïd Bendahhou, Michael C. Sanguinetti, and Louis J. Ptáček. Functional consequences of chloride channel gene ( clcn1) mutations causing myotonia congenita. Neurology, 54(4):937–942, February 2000. URL: http://dx.doi.org/10.1212/WNL.54.4.937, doi:10.1212/wnl.54.4.937. This article has 71 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1212/WNL.54.4.937)

[12. (Wu2002Novel) F.-F. Wu. Novel clcn1 mutations with unique clinical and electrophysiological consequences. Brain, 125(11):2392–2407, November 2002. URL: http://dx.doi.org/10.1093/brain/awf246, doi:10.1093/brain/awf246. This article has 71 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awf246)

[13. (Wang2019Structure) Kaituo Wang, Sarah Spruce Preisler, Liying Zhang, Yanxiang Cui, Julie Winkel Missel, Christina Grønberg, Kamil Gotfryd, Erik Lindahl, Magnus Andersson, Kirstine Calloe, Pascal F. Egea, Dan Arne Klaerke, Michael Pusch, Per Amstrup Pedersen, Z. Hong Zhou, and Pontus Gourdon. Structure of the human clc-1 chloride channel. PLOS Biology, 17(4):e3000218, April 2019. URL: http://dx.doi.org/10.1371/journal.pbio.3000218, doi:10.1371/journal.pbio.3000218. This article has 74 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.pbio.3000218)